In the BioHarmony Drug Report Database
Fluocinolone acetonide
Capex, Derma-smoothe/fs, Dermotic, Iluvien, Retisert, Synalar, Synalar-hp, Yutiq (fluocinolone acetonide) is a small molecule pharmaceutical. Fluocinolone acetonide was first approved as Capex on 1982-01-01. It is used to treat atopic dermatitis, facial dermatoses, foot dermatoses, hand dermatoses, and inflammation amongst others in the USA. The pharmaceutical is active against glucocorticoid receptor. Neo-synalar’s patent is valid until 2027-08-12 (FDA).
Trade Name
|
Capex, Derma-smoothe/fs, Dermotic, Iluvien, Retisert, Synalar, Synalar-hp, Yutiq |
|---|---|
Common Name
|
fluocinolone acetonide |
ChEMBL ID
|
CHEMBL989 |
Indication
|
atopic dermatitis, facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses, pruritus, psoriasis, scalp dermatoses |
Drug Class
|
Steroids (not prednisolone derivatives); topical steroids (acetal derivatives) |
Image (chem structure or protein)